1. Carulli C, Felici I, Martini C, et al. Total hip arthroplasty in
haemophilic patients with modern cementless implants. J
Arthroplasty. 2015; 30(10):1757-1760. doi:
10.1016/j.arth.2015.04.035.
2. Mortazavi SJ, Daneshpoor SMM, Shafiei SH. Total hip
arthroplasty in patients with hemophilia: what do we know?
Arch Bone Jt Surg. 2023; 11(7):434-440. doi:
10.22038/ABJS.2023.58812.291.
3. Strauss AC, Rommelspacher Y, Nouri B, et al. Long-term
outcome of total hip arthroplasty in patients with
haemophilia. Haemophilia. 2017; 23(1):129-134. doi:
10.1111/hae.13045.
4. Wu GL, Zhai JL, Feng B, Bian YY, Xu C, Weng XS. Total hip
arthroplasty in hemophilia patients: a mid-term to long-term
follow-up. Orthop Surg. 2017; 9(4):359-364. doi:
10.1111/os.12354.
5. Wang SH, Chung CH, Chen YC, Cooper AM, Chien WC, Pan RY.
Does hemophilia increase risk of adverse outcomes following
total hip and knee arthroplasty? A propensity score-matched
analysis of a nationwide, population-based study. J
Arthroplasty 2019; 34(10):2329-2336.e1. doi:
10.1016/j.arth.2019.05.062.
6. Chiasakul T, Buckner TW, Li M, Vega R, Gimotty PA, Cuker A. Inhospital complications and readmission in patients with
hemophilia undergoing hip or knee arthroplasty. JB JS Open
Access 2020; 5(2):e0085. doi: 10.2106/JBJS.OA.19.00085.
7. Gillinov SM, Burroughs PJ, Moore HG, Rubin LE, Frumberg DB,
Grauer JN. Total hip arthroplasty in patients with classic hemophilia: a matched comparison of 90-day outcomes and 5-
year implant survival. J Arthroplasty. 2022; 37(7):1333-1337.
doi: 10.1016/j.arth.2022.02.107.
8. Hernandez N, Kim B, Cochrane NH, Ryan SP, Seyler TM.
Midterm results of contemporary uncemented total hip
arthroplasty in patients 45 years or younger. Orthopedics.
2023; 46(1):e45-e51. doi: 10.3928/01477447-20221024-04.
9. Fransen BL, Bengoa FJ, Neufeld ME, Sheridan GA, Garbuz DS,
Howard LC. Thin highly cross-linked polyethylene liners
combined with large femoral heads in primary total hip
arthroplasty show excellent survival and low wear rates at a
mean follow-up of 12.8 years. Bone Joint J. 2023; 105-
B(1):29-34. doi: 10.1302/0301-620X.105B1.BJJ-2022-
0812.R1.
10. Chen AG, Sogbein OA, McClure JA, et al. Total hip arthroplasty
in patients aged 40 to 60 years old: a population-based study.
J Arthroplasty. 2023; 38(7S):S83-S88.e2. doi:
10.1016/j.arth.2023.04.027.
11. Wooster BM, Kennedy NI, Dugdale EM, et al. Contemporary
outcomes of primary total hip arthroplasty in patients with
inflammatory arthritis. Bone Joint J. 2023; 105-B (7):768-774.
doi: 10.1302/0301-620X.105B7.BJJ-2023-0220.R1.
12. Parilla FW, Youngman TR, Layon DR, et al. Excellent 20-year
results of total hip arthroplasty with highly cross-linked
polyethylene on cobalt-chromium femoral heads in patient's
≤50 years. J Arthroplasty. 2024; 39(2):409-415. doi:
10.1016/j.arth.2023.08.025.
13. Parilla FW, Anthony CA, Bartosiak K, Pashos GE, Thapa S,
Clohisy JC. Ten year outcomes of contemporary total hip
arthroplasty in adolescent and young adult patients are
favorable. J Arthroplasty. 2024; 39(3):754-759. doi:
10.1016/j.arth.2023.09.032.
14. Ennis HE, Lamar KT, Johnson RM, Phillips JL, Jennings JM.
Comparison of outcomes in high versus low activity level
patients after total joint arthroplasty. J Arthroplasty. 2024;
39(1):54-59. doi: 10.1016/j.arth.2023.06.031.
)